Related by context. Frequent words. (Click for all words.) 61 analyst Mark Schoenebaum 60 Raises PT 59 Reiterates Buy Rating 58 Maintains Buy 58 Piper Jaffray PJC 58 analyst Jami Rubin 57 Joel Sendek 57 Reiterates Buy 57 Geoffrey Porges 57 Maintains Buy Rating 56 Therapeutic Competitors 56 Arthritis Drug 56 Barclays Maintains 56 Analysts Downgrade 55 Osteoporosis Drug 55 gets USFDA nod 55 please visit www.ml.com 55 Jon LeCroy 55 Seamus Fernandez 54 Co. Incorporated Attn 54 Second Quarter Profit Rises 54 FBR Capital Maintains 54 analyst Stephen Tusa 54 analyst Larry Biegelsen 54 Karl Heinz Koch 54 Daniel Berenbaum 54 2Q Profit Up 54 Inc Therapeutic Competitors 54 Analysts Begin Coverage 53 Navid Malik 53 Ben Reitzes 53 Tao Levy 53 OSI Pharma 53 analyst Maynard Um 53 analyst Laura Champine 53 WestLB Panmure 53 MLNM 53 analyst Bill Pecoriello 53 Onyx Pharma 53 Inc. NASDAQ HGSI 53 PHARMACEUTICALS 53 Cuts FY# EPS 53 J.P. Morgan 53 Broker Roundup 53 Vytorin combines 53 ImmunoCellular Therapeutics 53 Presents Positive 53 analyst Joseph Greff 53 Co MRK 53 Guides Q4 52 Boosts Outlook 52 Puts Purchased 52 Guides Q3 52 Mabthera 52 Tops Expectations 52 Michael Linenberg 52 Above Consensus 52 Lowers Guidance 52 reaffirmed Outperform rating 52 Approaching Resistance 52 2Q Profit Jumps 52 Robert Breza 52 Analysts Upgrades Downgrades 52 Maynard Um 52 Guides Q1 52 Damien Conover 52 4Q Profit Jumps 52 analyst Benjamin Reitzes 52 1Q Profit Jumps 52 By Gustav Sandstrom 52 Viropharma 52 analyst Bruce Harting 52 analyst Nikos Theodosopoulos 52 Bristol Myers BMY 52 Neutral Weight 52 Weight Loss Drug 52 analyst Heather Bellini 52 analyst Ehud Gelblum 52 Cuts FY# 52 Meets Estimates 52 Celgene NASDAQ CELG 51 Forecast Quick Facts 51 Anacetrapib 51 Bristol Myers NYSE BMY 51 motesanib 51 2Q Profit Rises 51 Guides Q2 51 Profit Dips 51 Equalweight 51 F3Q 51 IDFC SSKI 51 Webcast Presentation 51 Andrew Garthwaite 51 Equinet AG 51 analyst Inder Singh 51 VP Exercises Options 51 Lifts FY# EPS 51 Inc. FY# Q3 51 Antipsychotic 51 Beat Expectations 51 Drug Shows Promise